The developmental viability of the preimplantation embryo requires the successful formation of a cluster of pluripotent stem cells called the inner cell mass. Development is variably compromised by a range of exogenous stressors (including their production by assisted reproductive technologies). Inbred C57BL/6 strain embryos are particularly susceptible to the stresses associated with embryo culture, whereas hybrid embryos are more resistant, and this is accounted for in part by the overexpression of transformation-related protein 53 in cultured inbred embryos compared with similarly treated hybrid embryos or embryos not subjected to culture. We show here that this loss of viability is a consequence of the Trp53-dependent reduction in the capacity of blastocysts to form a proliferating inner cell mass. Formation of the trophectodermal line was not adversely affected by these stresses.
INTRODUCTION
The preimplantation phase of mammalian development results in the formation of a blastocyst that is capable of implantation into the uterus. The blastocyst comprises two discrete stem cell populations, the trophectoderm (TE) and inner cell mass (ICM) lineages. The blastocyst is formed as a consequence of a series of reductive mitoses of the newly fertilized zygote. In the mouse, the cells of the embryo form tight attachments with their neighbors after approximately five cell cycles, in a process known as compaction. This results in some cells being entirely enclosed by exterior cells. Compaction allows fluid to be pumped into intercellular spaces within the embryo to form a cavity between adjacent cells (the blastocoel cavity). The expansion of this cavity (cavitation) results in the polarization of the embryo and the formation of the blastocyst. Cavitation causes the outer cells to become attenuated and adopt an epithelial appearance and function, forming the TE. The interior cells retain an undifferentiated morphology and become the ICM. These two cell populations have distinct developmental fates; the TE goes on to form the trophoblast and eventually the embryonic component of the placenta, whereas the ICM forms the embryo proper and extraembryonic membranes. Under appropriate experimental conditions the ICM is also the source of embryonic stem cell (ESC) colonies. The cues, if any, that inform the indeterminant cells of the cleavage-stage embryo of their eventual lineage is a matter of much current debate and investigation [1] [2] [3] . It is clear, however, that the early embryo is highly regulative and that a given cell may follow different developmental fates under different circumstances. By the time the blastocyst is fully formed this regulative capacity is partially constrained. Thus, cells of the TE have limited, if any, capacity to be redirected to the ICM lineage; however, the mouse ICM remains totipotent, having the potential capacity to regenerate the TE and all of the cell lineages of the developing embryo [4] . The factors that govern the formation and maintenance of the pluripotent state of the ICM are currently of wide interest in reproductive, developmental, and regenerative medicine.
The failure of the preimplantation embryo to fulfill its complete developmental potential is considered to be a significant cause of subfertility in mammals. The preimplantation embryo is known to respond to a range of exogenous stressors by the elevated expression of the tumor suppressor, transformation-related protein 53 (TRP53) [5] . For example, the increased rates of embryopathy induced by hyperglycemia [6] , in vitro fertilization (IVF), or extended culture of zygotes in vitro [5, 7] are all at least partially ameliorated by the absence of Trp53 from the embryo (Trp53 À/À ). Human embryos produced by IVF techniques are also predisposed to increased TRP53, and the level of expression is related to morphological signs of the embryo's developmental potential [8, 9] .
The preimplantation embryo seems to be particularly susceptible to exogenous stressors, which may lead to embryonic demise [5, 10, 11] . This is evident after embryos are created by procedures such as IVF [12, 13] . The preimplantation embryo produced or cultured in vitro is characterized by a generally slower rate of growth [14, 15] and altered patterns of gene expression [16] [17] [18] [19] , and these embryos posses relatively fewer cells within their ICM [20] . Normal ICM formation requires the expression of the pluripotency factor POU5F1 [21] , and it has been observed that cultured embryos tend to express less POU5F1 [22] .
Embryos from many inbred lines are particularly sensitive to exogenous stressors compared with hybrid embryos [23] , and thus they serve as powerful models for examining the underlying causes of embryonic demise. Upon embryo transfer, cultured inbred embryos have a markedly reduced capacity to form fetuses [5] . It was noted that embryo culture had a much greater effect on the capacity of transferred blastocysts to form viable fetuses than on the capacity of embryos to implant after embryo transfer [5] . One interpretation of this observation is that a major effect of the miscellaneous stresses of culture is directed primarily at the developmental potential of the ICM lineage (embryo/fetus formation) rather than the TE (trophoblast and placenta formation). However, the examination of cells into these lineages after implantation is difficult in vivo. The process of blastocyst outgrowth in vitro is considered to be partially homologous to the implantation process and allows a tractable experimental model for following the fate of cells in the embryo.
The aim of the current study was to identify whether the miscellaneous stresses induced during embryo culture reduce the developmental potential of embryos by reducing the capacity of the embryo to form a proliferating ICM in a Trp53-dependent manner. Mouse Embryo Collection, Culture, and Treatments Female mice, 6 wk old, were superovulated by intraperitoneal injection of 5 IU of equine chorionic gonadotropin (Folligon; Intervet International, Boxmeer, The Netherlands) followed 48 h later by 5 IU of human chorionic gonadotropin (hCG; Chorulon; Intervet). Females were then paired with males of proven fertility. Pregnancy was confirmed by the presence of a copulation plug. Embryos were collected from the reproductive tract in Hepes-buffered modified human tubal fluid medium (Hepes-modHTF) at the times indicated in experiments, and then cultured in modified human tubal fluid medium (modHTF) [24] . These culture conditions, although widely used in the past for clinical IVF, provide limited support for embryo development and thus have been widely used as a model for studying the adverse effects of culture. All components of the media were tissue culture grade (Sigma, St. Louis, MO) and contained 3 mg of bovine serum albumin per milliliter unless otherwise stated (CSL Ltd., Melbourne, Australia). Embryo collection and culture were as described [24] . Zygotes (20-21 h after hCG) were freed from their surrounding cumulus cells by brief exposure to 300 units of hyaluronidase (Sigma). They were assigned to various treatments as required in modHTF and cultured as 10 embryos per 10-ll volumes in 60-well plates (Nunc, Naperville, IL). The developmental stage and morphology were assessed by visualizing the embryos with an inverted phase-contrasted microscope. Fresh blastocysts were collected by flushing the uterus 90 h after hCG. Differential staining of ICM/TE within blastocysts was achieved by incubating for 10 sec in bovine serum albumin-free Hepes-modHTF containing 100 lg/ml propidium iodide (PI; Sigma) and 1% Triton X-100, followed by 1 h in 100% ethanol with 25 lg/ml bisbenzimide at 48C. The outer TE cells stain with both PI and bisbenzimide, and inner cells stain only with bisbenzimide. Embryos were then mounted in PBS:glycerol (1:1), and cell counts were performed under a Nikon epifluorescence microscope.
MATERIALS AND METHODS

Animals
Blastocyst Outgrowth and ESC Formation
Postblastocyst culture was performed individually in ESC medium. All reagents were from Invitrogen Life Technologies (Carlsbad, CA) unless otherwise stated. This medium consisted of knockout-Dulbecco modified essential medium (DMEM) supplemented with 2 mM L-glutamine, 100 lM MEM nonessential amino acid solution, 100 lM b-mercaptoethanol, antibiotics (50 units of penicillin per ml and 50 lg of streptomycin per ml; Sigma), 10% (v/v) heat-inactivated ESC qualified fetal bovine serum, and 1000 units of murine leukemia inhibitory factor per milliliter (ESGRO; Chemicon International Inc.; Temecula, CA). The ICM component of the blastocyst outgrowth was microsurgically resected after 96 h of blastocyst culture in 10-ll volumes of ESC medium. Resected ICMs were replated in fresh 10-ll drops of ESC medium for a further 96 h before genotyping. The proliferative capacity of cells within embryos was assessed by the capacity of cells of each lineage to incorporate bromodeoxyuridine (BrdU; Sigma). Both fresh and cultured blastocysts were placed in ESC media, and at 0, 24, or 48 h they were transferred to ESC media containing 20 lM BrdU for 3 h. Embryos were fixed with 2% paraformaldehyde (Sigma) in PBS for 30 min, permeabilized with PBS containing 0.5% Tween-20 (Sigma) and 0.5% Triton X-100 (Bio-Rad) for 30 min, treated with cold 4N HCl for 10 min to denature DNA, blocked in 30% serum in PBS for 2 h, and stained overnight with a mouse monoclonal antiBrdU (diluted 1:150 in PBS with 5% serum; Sigma) at 48C. Embryos were then incubated for 1 h in fluorescein isothiocyanate-coupled secondary antibody for the immunolocalization of BrdU and counterstained with 1 lg/ml PI in PBS for 5 min for nuclei localization.
Embryo Transfer
This was performed as previously described [25] . Briefly, morphologically normal, zona pellucida-intact blastocysts were used in embryo transfer experiments. Groups of 20 blastocysts were surgically transferred to each uterine horn on Day 2.5 postcoitus of pseudopregnant Quackenbush outbred recipient female mice. The number of neonates born was recorded. Although this number of transferred embryos is higher than the number present following normal conception, we have found that because of the reduced viability of embryos, this use of supernumerary transfer optimizes the implantation rate.
Genotyping
Whole preimplantation-stage embryos, trophoblastic cells from outgrowths, samples of cell colonies generated from resected ICM, and tail tissues of neonates born from embryo transfer were genotyped for Trp53 status. Embryos were subjected to four rounds of freeze-thaw in liquid nitrogen, cell lines had DNA extracted using the QuickExtract Solution 1.0 (Epicentre). DNA was then subjected to genotyping by PCR using three primers (Sigma-Genosys): two sense-oriented primers from exon 6 of Trp53 
Statistical Analysis
Statistical analyses were performed on an SPSS statistical package (version 11.5). Detailed description of the statistical models used is provided in the legend to each figure or in text.
RESULTS
The design of this experiment is shown in Figure 1 . Embryos were collected from either B6 or B6CB F1 (hybrid) TRP53 AND ICM FORMATION background females that had been mated with males of the same strain. Embryos were collected at the zygote (cultured) or blastocyst (fresh) stage. Zygotes were cultured for 96 h to the blastocyst stage. Cultured and fresh blastocysts were then cultured under conditions that supported blastocyst outgrowth and ICM proliferation. Defined ICMs were resected and placed into fresh drops of ESC medium (one ICM per 10 ll) to allow formation of proliferating cell lines. A high proportion of the embryos collected directly from the reproductive tract 90 h after hCG were blastocysts, showing that zygotes of both strains produced a high proportion of blastocysts in vivo ( Fig.  2A) . When zygotes were cultured for 96 h, there was a reduction in the proportion that formed blastocysts. However, the B6 strain produced fewer blastocysts in both cases, resulting in an additive disadvantage for B6 zygotes subjected to culture in their capacity to form blastocysts compared with hybrid embryos.
The proportion of morphological blastocysts that formed ICM after outgrowth (Fig. 2B, i and ii) was highest for fresh hybrid blastocysts, followed by fresh B6 blastocysts. Zygote culture caused a marked reduction in the capacity of both strains to form outgrowths, and there was an additive effect of culture on B6 zygotes' capacity to form outgrowth. In all treatments, many of the blastocysts that did not form a viable ICM instead only formed cells with trophoblastic morphology (Fig. 2B, iii and iv) . It was of interest that embryos that formed a morphologically distinct ICM after outgrowth had a high capacity for forming proliferating cell colonies after their ICM was resected (Fig. 2, A , Bv, and Bvi). Hybrid embryos that formed successful outgrowths were more successful than B6 embryos in forming cell colonies, but there was no further additive adverse effect of zygote culture. Upon colony expansion, these cells were characterized by their capacity for self-renewal, their high nuclear:cytoplasmic ratios, prominent nucleoli, and the formation of compact flat colonies with defined edges. Representative samples of cells were shown to stain with an anti-POU5F1 antibody.
To analyze the fate of the cell populations in the embryo further, a new set of outgrowth cultures were performed on fresh and cultured blastocysts of B6 and hybrid embryos. Rather than allowing the embryos to proceed to full outgrowth, we first analyzed the distribution of cells within the ICM and TE of blastocysts and then their proliferative capacity (as determined by incorporation of BrdU) over the first 48 h in ESC medium. Differential staining of the ICM and TE (Fig.  3A) showed that at the time embryos were introduced to ESC media, cultured embryos had more cells than their fresh counterparts (P , 0.001), and this effect was more pronounced in hybrid embryos (P , 0.05). This difference is accounted for by the cultured embryos being 18 h older than fresh ones, even though they had reached similar stages of development. The number of ICM cells within embryos relative to the total cell number was greater in B6 embryos (P , 0.05) and less in cultured embryos of both strains (P , 0.01). As the number of ICMs (Fig. 3Bi ) and trophoblast cells (Fig. 3Bii) increased during 48 h in ESC media, the proportion of ICM cells that were proliferative (BrdU-positive) in cultured embryos became progressively smaller with time in culture compared with fresh embryos (P , 0.001). Trophectoderm cells, by contrast, showed no difference in proliferation between treatments. These two experiments show that culture of zygotes reduced the proliferative capacity of the ICM. This corresponded with their reduced capacity to form outgrowths containing a proliferating ICM, and this was more severe in zygotes of B6 background ( Figs. 2A and 3Bi ). Outgrowths possessing a defined ICM had a high likelihood of producing proliferating colonies upon resection, especially if they were of hybrid genetic background. Once an ICM was formed, prior culture did not cause any further reduction in their viability. Thus, the primary defect that occurs following the culture of zygotes, particularly in susceptible strains such as B6, is their reduced capacity to form a proliferating ICM.
An important aspect of the experimental design of the first experiment ( Fig. 1) is that parents of both the B6 and hybrid backgrounds were haploinsufficient for Trp53 (Trp53
). It is known that TRP53 expression after culture of B6 zygotes has a negative impact on the developmental potential of embryos following embryo transfer [5] . Mating Trp53 þ/À parents allows the role of TRP53 in ICM formation to be assessed directly by comparing the developmental potential of Trp53
, and Trp53
À/À sibling embryos in each background strain. Embryos that successfully formed outgrowths with defined proportion of embryos that formed morphologically normal blastocysts ( n ) from B6 or hybrid background parents. Embryos were collected directly from the uterus (Fresh) 90 h after hCG or collected as zygotes (18 h after hCG) and cultured for 96 h (Cultured). Morphological blastocysts from both strains and both treatments were allowed to undergo outgrowth for 96 h. The proportion of blastocysts that formed outgrowths with defined ICM was recorded (&). Defined ICMs were microsurgically resected and placed in separate culture. The proportion of ICMs that displayed extensive proliferation after 96 h was recorded (&). The number of embryos commencing treatment in each group is shown above the boxes. Logistic regression analysis showed that there was an overall significant effect of strain and culture on the proportion of embryos that formed blastocysts (P , 0.001) and those that formed outgrowths with defined ICM (P , 0.001). There was a small effect of strain (P , 0.05) but not culture (P . 0.05) on the proportion of resected ICMs that formed proliferating cell cultures. B) Two representative photos each of embryos that showed normal outgrowth with defined ICM (i and ii), compared with embryos that showed some formation of cells with the morphology of a trophoblast but lacking a well-formed ICM (iii and iv) and the cell colonies resulting from proliferating ICM after resection and culture (v and vi). Bar ¼ 50 lm.
960
ICM and the proliferating cell colonies that resulted from resecting these ICM were Trp53 genotyped. Transmission distortion in favor of the Trp53-null allele is taken as evidence that the expression of TRP53 is a cause of the failure of embryos to achieve the developmental landmark. A significant transmission distortion in favor of the Trp53 À/À genotype was observed at the blastocyst outgrowth developmental landmark in embryos of B6 background, and this transmission distortion was more pronounced following culture from the zygote stage. No such transmission distortion was observed for embryos of hybrid background (Fig. 4A) . A very similar pattern of transmission distortion was observed after cell colonies were generated from resected ICM, but at this landmark, cultured hybrid zygotes also showed a small distortion in favor of the Trp53 À/À genotype (Fig. 4B ). An important control for the study was the determination of the genotypic distribution of blastocysts collected directly from the uterus without further culture. These did not differ (P . 0.05) from the expected Mendelian genotypic distribution (B6.Trp53
, respectively). Thus, the transmission distortion in favor of B6.Trp53 À/À after outgrowth was not a consequence of a higher incidence of formation of Trp53 À/À zygotes and blastocysts, but rather resulted from the preferential development of Trp53 À/À embryos following culture from the zygote stage. These results show that culture . Thus, embryos produced were Trp53
To assess the impact of genotype on the capacity of the embryo to achieve developmental endpoints, the genotype of each individual embryo was determined for those achieving (A) successful outgrowth with a defined ICM and (B) ICM that formed a proliferating colony upon resection. The P value above each graph shows the statistical analysis (chi-square) of each genotype relative to the expected Mendelian distribution. Lines connecting treatments (and the P values above them) show the treatments that caused a significant shift in the genotypic distribution relative to each other, as assessed by multinomial regression analysis. NS, not significant.
TRP53 AND ICM FORMATION
of B6 zygotes caused a marked Trp53-dependent loss of their capacity to form a proliferating ICM. It further shows that since such transmission distortion does not occur after normal mating and pregnancy of such haploinsufficient parents [26] , the favored development of Trp53 À/À embryos is a consequence of the response of embryos to the miscellaneous cellular stressors imposed by the culture environment.
It was previously shown that the absence of Trp53 protected B6 zygotes (Trp53
) from some of the adverse effects of culture; a higher proportion of cultured B6.Trp53
À/À blastocysts formed normal fetuses after embryo transfer than their B6.Trp53 þ/þ or B6.Trp53 þ/À siblings [5] . In the current study, hybrid Trp53 À/À zygotes (F2.Trp53 À/À ) had no selective advantage over wild-type embryos in development to the blastocyst outgrowth landmark. To assess whether the blastocyst outgrowth procedure faithfully reports the developmental potential of the embryo, blastocysts derived from zygotes collected from F1.Trp53 þ/À mating were subjected to embryo transfer, and the resulting neonates were genotyped. Nineteen pregnancies resulted from the transfer of 380 embryos, and these produced 124 normal neonates (36.6%). The genotypic distribution of the resulting pups did not differ from the expected Mendelian distribution (P . 0.05; Fig. 5 ). The transmission distortion of Trp53 À/À embryos in embryos susceptible to culture stressors (B6) was not observed in resistant embryos (hybrid). Thus, the relative difference in the Trp53-dependent susceptibility of B6 and hybrid embryos to the adverse effects of culture that was detected by ICM formation in vitro was faithfully reflected by differences in their capacity to form viable fetuses upon embryo transfer.
DISCUSSION
A range of external stressors compromise fertility in mammals and can act at a number of levels of the reproductive process, including compromising the developmental viability of the early embryo. In our experimental model, the culture of inbred mice in modHTF media provides for a defined loss of developmental viability compared with hybrid embryos that are relatively resistant to this loss of viability [5] . The medium used is a minimal essential medium for preimplantation embryo growth, and is thus not an optimized formulation. The nature of the stresses induced by such culture have not been fully defined, but they included the relative deprivation of autocrine trophic ligands [24, 27, 28] . It is known that culture can lead to the increased presence of TRP53 [5] and related stress proteins, such as mitogen-activated protein kinase 8 interacting protein 3 [29] and mitogen-activated protein kinase 14 [30] . The present study confirms that the expression of a universal effector of cell stress, TRP53, in susceptible embryos (B6) compromised the formation of a viable ICM as assessed by their capacity to form proliferative cells upon outgrowth. Embryos that were resistant to these stressors (hybrid) were more likely to have proliferative ICM after outgrowth in vitro. It shows that the transmission distortion in favor of Trp53 À/À cultured B6 embryos after embryo transfer [5] did not occur for Trp53 À/À of hybrid background. Thus, the TRP53-dependent loss of the viability of susceptible embryos appears to be due to preferential loss of development of cells of the ICM lineage. This result may explain why culture of these embryos has only a marginal effect on the rate at which transferred embryos form implantation sites, but a much higher effect on the proportion of these implanted embryos that form viable fetuses [5] . This role of the universal effector of cellular stress responses, TRP53, in regulating the viability and pluripotency of the embryo indicates that investigation of its role in other forms of stress-induced loss of embryo viability is warranted.
The expression of TRP53 is known to be a key regulator of cell cycle progression, cell survival, and differentiation. The latency of TRP53 expression in the early embryo is normally maintained by the action of the PI3 kinase, AKT, MDM2 signaling pathway [27, 31] . This pathway leads to the phosphorylation and activation of MDM2, which in turn induces the ubiquitin-mediated degradation of TRP53 by the proteosome. The central role for MDM2 in regulating the levels of TRP53 expression is consistent with observations that Mdm2 À/À embryos fail to develop past the blastocyst stage. Furthermore, this phenotype can be reversed by the compound Mdm2
Trp53
À/À mutation in the B6 background [32] . The cells of the early embryo are considered to be highly regulative. This study shows that exogenous stressors that cause increased TRP53 expression bias this regulation against the formation of a normal ICM. A role for TRP53 in the reduced development of the ICM might occur at multiple levels. These include deficits in proliferation or cell survival (e.g., increased apoptosis) or alterations in the differentiation state of affected cells. Canonically, TRP53 acts as an effector of cell cycle checkpoints. These checkpoints can occur at the G 1 -S-phase and G 2 -M-phase boundaries (reviewed in Pietenpol and Stewart [33] ). This effect can be mediated by TRP53-mediated expression of effectors such as cyclin-dependent kinase inhibitor 1A (P21) [34] . The reduced proliferative capacity of ICM after 48 h in outgrowth media, as assessed by BrdU incorporation, is consistent with the activation of a G 1 -Sphase checkpoint, but it is not definitive evidence for this. Induction of cell death is also a canonical role for TRP53 [33] . This is normally by apoptosis but can also involve autophagy [35] . TRP53 can activate expression of BCL2-associated X protein (Bax), which is commonly involved in apoptosis, and culture of B6 embryos resulted in increased staining for BAX in a TRP53-dependent manner [7] . TRP53 can also transiently repress the expression of baculoviral IAP repeat-containing 5 (Birc5, also known as survivin) [36] , and it is known to þ/À parents. The results for the B6 cross were reported previously [5] . The number of neonates within each genotype is shown above the bars. The P value shows the statistical analysis (chi-square) of each genotype relative to the expected Mendelian distribution. NS, not significant.
962
contribute to the antiapoptotic activities of the embryotrophin transforming growth factor alpha in mouse blastocysts [37] . Although TRP53 is commonly thought of as a transcription factor capable of generating a very diverse transcriptome in affected cells, it is also capable of acting with corepressors (such as transcriptional regulator SIN3A) to induce genespecific repression [38] . In ESCs, an important target for such repression is NANOG. Increased TRP53 expression in ESCs induced by either DNA damage [39] or treatment with Nutlin-3 [40] caused the downregulation of Nanog and resulted in a predisposition toward differentiation of the affected cells. The Nanog promoter possesses two TRP53 consensus binding sites, and these are required for repression of Nanog in ESCs [39] . Nanog À/À blastocysts seem morphologically normal, but they fail to produce a proliferating ICM upon outgrowth in vitro. These blastocysts do form normal-looking trophoblast cells upon outgrowth [41] . Thus, Nanog À/À embryos show a similar (although more severe) phenotype to many B6 embryos cultured from the zygote stage. Further investigation is required to determine the relative roles of proliferative decline, cell death, and altered differentiation state in this stress-induced bias against the maintenance of the ICM lineage.
There is considerable variability between strains and species in their capacity to undergo outgrowth and form proliferating viable cell lines [21, 42] . It will be of interest to determine the extent to which increased TRP53 expression accounts for all of this variability. It is also known that a range of acute stressors can alter developmental pathways, and it has been proposed [10] that some stress responses may be a normal part of the development. Yet, the current study shows that abnormal stressors compromise this role with excess TRP53, preventing the formation of a core population of pluripotent cells. It will be important to determine whether all external stressors exert their primary effects through the increased expression of TRP53 and consequent failure of the embryo to form a normal ICM.
